Serum amyloid a as an independent prognostic factor for renal cell carcinoma - a hospital based study from the western region of nepal

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 5, 2012, Pages 2253-2255

  Mittal, Ankush ^a   Poudel, Bibek ^a   Pandeya, Dipendra Raj ^a   Gupta, Satrudhan Pd ^a   Sathian, Brijesh ^a   Yadav, Shambhu Kumar ^a  

^a MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

Author keywords

Nepal; Prognostic factor; Renal cell carcinoma; Serum amyloid A

Indexed keywords

SERUM AMYLOID A; TUMOR MARKER;

ARTICLE; BLOOD; CANCER GRADING; CANCER STAGING; FOLLOW UP; HOSPITAL; HUMAN; KIDNEY CARCINOMA; KIDNEY TUMOR; METABOLISM; NEPAL; PROGNOSIS; RETROSPECTIVE STUDY;

CARCINOMA, RENAL CELL; FOLLOW-UP STUDIES; HOSPITALS; HUMANS; KIDNEY NEOPLASMS; NEOPLASM GRADING; NEOPLASM STAGING; NEPAL; PROGNOSIS; RETROSPECTIVE STUDIES; SERUM AMYLOID A PROTEIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84872676732     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.5.2253     Document Type: Article

References (13)

1. Chambers RE, Whicher JT (1983). Quantitative radial immunodiffusion assay for serum amyloid A protein. J Immunol Methods, 59, 95-103.
2. Eichelberg C, Junker K, Ljungberg B, et al (2009). Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability. Eur Urol, 55, 851-63.
3. Fischer K, Theil G, Hoda R, et al (2012). Serum amyloid a: a biomarker for renal cancer. Anticancer Res, 32, 1801-4.
4. Johnson TV, Ali S, Abbasi A, et al (2011). Intra tumor C-reactive protein as a biomarker of prognosis in localized renal cell carcinoma. J Urol, 186, 1213-7.
5. Johnson TV, DeLong J, Master VA (2012). C-reactive protein: a clinically useful biomarker in renal cell carcinoma. JAAPA, 25, 45-7.
6. Kimura M, Tomita Y, Imai T, et al (2001). Significance of serum amyloid a on the prognosis in patients with renal cell carcinoma.
7. Kisilevsky R, Manley PN (2012). Acute-phase serum amyloid A: perspectives on its physiological and pathological roles. Amyloid, 19, 5-14.
8. Luke C, Sargent N, Pittman K, et al (2011). Epidemiology of cancers of the kidney in an Australian population. Asian Pac J Cancer Prev, 12, 2893-9.
9. Malle E, Sodin-Semrl S, Kovacevic A (2009). Serum amyloid A: an acutephase protein involved in tumour pathogenesis. Cell Mol Life Sci, 66, 9-26
10. Mohan S, Mohanasenthil, Paul SF, et al (2009) Interleukin-4-receptor alpha gene polymorphism and the risk of renal cell carcinoma in a South Indian population. APJCP, 10, 295-8.
11. Paret C, Schön Z, Szponar A, et al (2010). Inflammatory protein serum amyloid A1 marks a subset of conventional renal cell carcinomas with fatal outcome. Eur Urol, 57, 859-66.
12. Singam P, Ho C, Hong GE, et al (2010). Clinical characteristics of renal cancer in Malaysia: a ten year review. Asian Pac J Cancer Prev, 11, 503-6.
13. Wood SL, Rogers M, Cairns DA, et al (2010). Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer. Br J Cancer, 103, 101-11.